Association for Psychological Science announces new convention plan to foster global psychological research
Meeting Announcement
The Association for Psychological Science, the leading global organization dedicated to advancing scientific psychology for the benefit of science and society, is revamping its roster of regularly scheduled events to better foster global scientific collaboration and environmental sustainability. Starting in 2025, APS will merge its Annual Convention and the biennial International Convention of Psychological Science (ICPS). The new APS Annual Convention will rotate outside of North America every 3 years.
A Cambridge Festival talk will examine the role of monarchies across the world and show how republics and their systems can sometimes morph into them – with a particular focus on the forthcoming United States Presidential election.
Oncotarget is proud to participate at the American Association for Cancer Research (AACR) Annual Meeting 2024, which convenes April 5-10 in San Diego, California.
Aging is proud to participate at the American Association for Cancer Research (AACR) Annual Meeting 2024, which convenes April 5-10 in San Diego, California.
The European Lung Cancer Congress 2024 is the annual appointment that brings together various experts in the field of thoracic oncology, including thoracic surgeons, respiratory physicians and pneumologists, medical and radiation oncologists, interventional radiologists and pathologists, to discuss the latest insights into the recent developments in the prevention, diagnosis and treatment of lung cancer.
The event will take place in Prague, Czech Republic, and through a dedicated virtual platform between 20-23 March.
As we eagerly anticipate the 2024 UKSG conference, it's time to mark our calendars and prepare for a unique event in scholarly communication. This year, the conference promises to be an invaluable opportunity for open access publishers and librarians to come together, share insights, and explore the latest advancements in scholarly publishing.
At Frontiers, we recognize the value of attending and sponsoring the UKSG conference. We're happy to showcase our latest products and services at booth #20 and highlight the pivotal role institutional partnerships play in shaping the future of academic publishing.
“Thank you for the excellent work you all do here"
The German Federal Minister of Health, Karl Lauterbach, visited IQWiG and thanked the staff for their commitment. He sees new tasks ahead for the Institute.
With the aim of addressing the most pressing environmental problems of our time, the Institute of Environmental Science and Technology of the Universitat Autònoma de Barcelona (ICTA-UAB) is organising the "Growth vs Climate Conference 2024" from 13-15 March 2024. The event will gather leading scientists, thinkers, policymakers, activists and journalists at the UAB campus in Cerdanyola del Vallès.
More than 120 people gathered for the 2024 Innovation Network for Fusion Energy (INFUSE) Workshop at the U.S. Department of Energy’s Princeton Plasma Physics Laboratory from Feb. 27-28. The event, which was sponsored by the DOE’s Office of Fusion Energy Sciences (FES), is a part of the INFUSE awards program that funds laboratories or universities so they can partner with private sector companies working on the science and technology solutions that will bring fusion energy to the power grid. To date, DOE has granted 90 awards, with most ranging from $100,000 to $350,000 for a 12-month project.
The Federation of European Neuroscience Societies (FENS) Forum 2024 will be taking place in Vienna, Austria, from 25 to 29 June 2024. Registration for media is free and is now open.
Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology will be held March 23–26 in San Antonio.Secure your front-row seat to cutting-edge findings, approaches and technologies in the biological sciences by registering for a complimentary press pass to attend in person or to access press materials electronically.
CAR-T cells are considered a major innovation in cancer therapy: The T cells – i.e. the immune system’s white blood cells – of people with cancer are altered in laboratories in such a way that they can specifically identify and eliminate tumour cells. People with previously incurable blood cancer diseases have been successfully treated in this way. Now the therapy is also being used for other diseases such as auto-immune diseases, infectious diseases, and cardiac fibrosis. In an interdisciplinary Leopoldina Symposium on Monday, 8 April and Tuesday, 9 April, international experts will discuss current CAR-T cell therapy approaches for these and other, non-malignant diseases.